Drugs / KLH-pulsed autologous dendritic cell vaccine
KLH-pulsed autologous dendritic cell vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00868114 Background | Jul 2006 → Jul 2013 | malignant pancreatic neoplasm | Leo W. Jenkins Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KLH-pulsed autologous dendritic cell vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00868114 ↗ |
| Modality | Vaccine | “dendritic cell vaccine” NCT00868114 ↗ |